Results 31 to 40 of about 393,600 (259)

Invasive Meningococcal Disease. Cuba, 1983- 2006

VacciMonitor, 2010
Invasive Meningococcal Disease (IMD) is a worldwide health problem. In Cuba, vaccination against meningococcal B-C has been carried out since 1989. The study aimed at describing the epidemiology of IMD in Cuba from 1983 to 2006 and at contributing to the
Antonio E. Pérez , Félix Dickinson, Rafael Llanes   +2 more
doaj   +1 more source

Epidemiology of invasive meningococcal disease worldwide from 2010–2019: a literature review

Epidemiology and Infection, 2023
The epidemiology of invasive meningococcal disease (IMD) is unpredictable, varies by region and age group and continuously evolves. This review aimed to describe trends in the incidence of IMD and serogroup distribution by age group and global region ...
Carmen Pardo de Santayana, M. Tin Tin Htar, J. Findlow, P. Balmer   +3 more
semanticscholar   +1 more source

Fatal Waterhouse-Friderichsen syndrome due to Neisseria meningitidis group B in a paediatric patient during the phone consultation era

Pediatria Polska, 2023
Owing to uncharacteristic initial symptoms and rapid progression, invasive meningococcal disease is still a challenge to diagnose and treat, even in high-income countries.
Marta Serafin, Ewa Czerwińska, Marian Koźbiał, Mariusz Leszczyński, Leszek Szenborn   +4 more
doaj   +1 more source

Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England.

Journal of Infection, 2023
OBJECTIVES In 2020, COVID-19 pandemic restrictions led to a major suppression of meningococcal disease in England. Here we describe the epidemiology of invasive meningococcal disease (in the three years prior to the COVID-19 pandemic and the three years ...
S. Clark, H. Campbell, Sonia Ribeiro, M. Bertran, Lloyd Walsh, A. Walker, Laura Willerton, A. Lekshmi, Xilian Bai, J. Lucidarme, S. Ladhani, R. Borrow   +11 more
semanticscholar   +1 more source

The rapid rebound of invasive meningococcal disease in France at the end of 2022.

Journal of Infection and Public Health, 2023
BACKGROUND Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic. A rebound in IMD cases was feared upon easing these measures.
Samy Taha, E. Hong, Mélanie Denizon, M. Falguières, A. Terrade, A. Deghmane, Muhamed-Kheir Taha   +6 more
semanticscholar   +1 more source

Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil

Emerging Infectious Diseases, 2022
Invasive meningococcal disease persists as a fulminant disorder worldwide. Although cases caused by Neisseria meningitidis serogroup X (MenX) occur infrequently, outbreaks have been reported in countries in Africa in recent decades. We report 2 cases of
Lucila O. Fukasawa, Bernadete L. Liphaus, Maria Gisele Gonçalves, Fabio T. Higa, Carlos H. Camargo, Telma R.M.P. Carvalhanas, Ana Paula S. Lemos   +6 more
doaj   +1 more source

Changing patterns of invasive meningococcal disease and future immunization strategies

Human Vaccines & Immunotherapeutics, 2023
Invasive meningococcal disease (IMD) is a life-threatening disease caused by Neisseria meningitidis and has high mortality rates. Survivors often exhibit long-term sequelae and reduced life expectancy. Disease incidence is highest in infants and toddlers,
M. Taha, R. Bekkat-Berkani, V. Abitbol
semanticscholar   +1 more source

Epidemiological Characteristics of Meningococcal Infection in Moscow

Эпидемиология и вакцинопрофилактика, 2020
Aims. The purpose of this study was to identify current epidemiological features of meningococcal infection in Moscow.Materials and methods. Cases of invasive meningococcal disease in Moscow from 2014 to 2018 and the biomaterial from patients with an ...
M. I. Gritsay, M. A. Koroleva, N. N. Fomkina, I. S. Koroleva   +3 more
doaj   +1 more source

Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease

BMC Family Practice, 2021
Background An early appropriate response is the cornerstone of treatment for invasive meningococcal disease. Little evidence exists on how cases with invasive meningococcal disease present at first contact to emergency medical services.
Nichlas Hovmand, Helle Collatz Christensen, Lene Fogt Lundbo, Håkon Sandholdt, Gitte Kronborg, Perle Darsø, Jacob Anhøj, Stig Nikolaj Fasmer Blomberg, Asmus Thun Bisgaard, Thomas Benfield   +9 more
doaj   +1 more source

Range of invasive meningococcal disease sequelae and health economic application – a systematic and clinical review

BMC Public Health, 2022
Invasive meningococcal disease (IMD) is uncommon, life-threatening, with many diverse sequelae. The aims were to: 1) comprehensively characterise the sequelae; 2) have a systematic application for sequelae impact in economic evaluation (EE).
Jing Shen, N. Begum, Yara Ruiz-Garcia, F. Martinón-Torres, R. Bekkat-Berkani, K. Meszaros   +5 more
semanticscholar   +1 more source